HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Revenue

In the year 2025, HLS Therapeutics had annual revenue of $55.50M USD, down -1.98%. HLS Therapeutics had revenue of $15.20M in the quarter ending December 31, 2025, a decrease of -2.23%.

• Revenue: $55.50M
• Revenue Growth: -1.98%
• P/S Ratio: 1.81
• Revenue / Employee: $603.26K
• Employees: 92
• Market Cap: 137.60M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	55.50M	-1.12M	-1.98%
Dec 31, 2024	56.62M	-6.46M	-10.23%
Dec 31, 2023	63.07M	1.61M	2.61%
Dec 31, 2022	61.47M	1.46M	2.43%
Dec 31, 2021	60.01M	3.90M	6.95%
Dec 31, 2020	56.11M	1.95M	3.60%
Dec 31, 2019	54.16M	-7.26M	-11.81%
Dec 31, 2018	61.42M	-13.67M	-18.20%
Dec 31, 2017	75.08M	21.05M	38.96%
Dec 31, 2016	54.03M	-	-